|
Index of reports
> Cases with Drug Interaction (10)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cancidas (Caspofungin) where reactions include drug interaction. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Cancidas side effects in 15 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-07
Patient: 15 year old female
Reactions: Overdose, Drug Interaction, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1 df, three times per week
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Dosage: unk
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin HCL
Dosage: unk
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, 3x/day
Start date: 2012-05-28
End date: 2012-06-04
Gentamicin
Dosage: unk
Start date: 2012-05-26
End date: 2012-05-30
Other drugs received by patient possibly interacting with the suspect drug:
Neoral
Dosage: 100 mg, 2x/day
Administration route: Oral
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin HCL
Dosage: 1 g, 2x/day
Start date: 2012-05-22
End date: 2012-06-03
Vfend
Dosage: 200 mg, 2x/day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-25
Vfend
Dosage: 200 mg, 2x/day
Administration route: Oral
End date: 2012-05-31
Other drugs received by patient: Colistin; Gentamicin; Neupogen
Possible Cancidas side effects in 15 year old female
Reported by a individual with unspecified qualification from Ireland on 2012-08-06
Patient: 15 year old female
Reactions: Nephropathy Toxic, Drug Interaction, Multiple Drug Overdose, Respiratory Distress, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cancidas
Dosage: ; iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-05-30
Cyclosporine
Dosage: 200 mg; ;po
Administration route: Oral
Indication: Aplasia
Start date: 2012-04-23
End date: 2012-05-31
Gentamicin
Dosage: 170 ug; ;iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-26
End date: 2012-05-30
Ticarcillin Disodium / Clavulanate Potassium (Claventin / 00973701 / )
Dosage: ; iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-01
Trimethoprim + Sulfamethoxazole
Dosage: ; tid; iv
Indication: Prophylaxis
Start date: 2012-04-01
Vancomycin
Dosage: 2 gm; iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-22
Voriconazole
Dosage: ; iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Atgam; Ciprofloxacin; Filgrastim
Possible Cancidas side effects in 15 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01
Patient: 15 year old female
Reactions: Overdose, Drug Interaction, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1 df, three times per week
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Dosage: unk
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin HCL
Dosage: unk
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, 3x/day
Start date: 2012-05-28
End date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Dosage: unk
Start date: 2012-05-26
End date: 2012-05-30
Neoral
Dosage: 100 mg, 2x/day
Administration route: Oral
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin HCL
Dosage: 1 g, 2x/day
Start date: 2012-05-22
End date: 2012-06-03
Vfend
Dosage: 200 mg, 2x/day
Administration route: Oral
End date: 2012-05-31
Vfend
Dosage: 200 mg, 2x/day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-25
Other drugs received by patient: Colistin; Neupogen; Gentamicin
Possible Cancidas side effects in 15 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient: 15 year old female
Reactions: Drug Interaction, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Dosage: iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-28
End date: 2012-06-04
Cyclosporine
Dosage: 200 mg;po
Administration route: Oral
Indication: Aplasia
Start date: 2012-04-23
End date: 2012-05-31
Gentamicin
Dosage: 170 ug;iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-26
End date: 2012-05-30
Ticarcillin Disodium / Clavulanate Potassium (Claventin / 00973701 / )
Dosage: iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-01
Trimethoprim + Sulfamethoxazole
Dosage: tid;iv
Indication: Prophylaxis
Start date: 2012-04-01
Vancomycin
Dosage: 2 gm;iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-22
Voriconazole
Dosage: 400 mg;iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Filgrastim; Colistin; Atgam
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Hepatic Failure, Drug Interaction, Respiratory Distress, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vfend
Administration route: Oral
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Respiratory Distress, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciproflaxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vfend
Administration route: Oral
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in 15 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-20
Patient: 15 year old female
Reactions: Overdose, Drug Interaction, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1 df, three times per week
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Dosage: unk
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin HCL
Dosage: unk
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, 3x/day
Start date: 2012-05-28
End date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Dosage: unk
Start date: 2012-05-26
End date: 2012-05-30
Neoral
Dosage: 100 mg, 2x/day
Administration route: Oral
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin
Dosage: 1 g, 2x/day
Start date: 2012-05-22
End date: 2012-06-03
Vfend
Dosage: 200 mg, 2x/day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-25
Vfend
Dosage: 200 mg, 2x/day
Administration route: Oral
End date: 2012-05-31
Other drugs received by patient: Neupogen; Colistin; Gentamicin
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-17
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vfend
Administration route: Oral
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-16
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Vfend
Administration route: Oral
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in 14 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-07
Patient: 14 year old female
Reactions: Renal Failure, Drug Level Increased, Cytolytic Hepatitis, Drug Interaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cancidas
Indication: Aspergillosis
Start date: 2011-09-13
End date: 2011-09-22
Rifadin
Administration route: Oral
Indication: Pulmonary Tuberculosis
Start date: 2011-06-08
End date: 2011-10-09
Tacrolimus
Administration route: Oral
Start date: 2011-09-16
Tacrolimus
Administration route: Oral
Indication: Lung Transplant
Start date: 2011-09-12
End date: 2011-09-15
Tacrolimus
Administration route: Oral
Start date: 2011-10-06
Tacrolimus
Administration route: Oral
Start date: 2011-09-21
Vfend
Administration route: Oral
Indication: Bronchopulmonary Aspergillosis
Start date: 2011-09-12
End date: 2011-09-28
Zithromax
Administration route: Oral
Start date: 2011-09-12
Zithromax
Administration route: Oral
Indication: Opportunistic Infection Prophylaxis
Start date: 2011-01-01
Other drugs received by patient: Rimifon; Creon; Mycophenolate Mofetil (Cellcept)
|
